IP Library Granted Patent US 10,513,689
Granted Patent B2
US 10,513,689 · App. 15/142,135 · Granted Dec 24, 2019

Culture media for multipotent stem cells

Inventor: Hyeonggeun Park (Sugar Land, TX)
Assignee: HOPE BIOSCIENCES, LLC
C12N5/0667C12N5/0653C12N5/0654C12N5/0655C12N2500/25C12N2500/32C12N2500/84C12N2500/90C12N2501/11C12N2501/21C12N2501/30C12N2501/999C12N2506/1384
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,513,689
App. No.
15/142,135
Granted
Dec 24, 2019
Kind
B2
Abstract

A culture medium for human adipose tissue derived mesenchymal stem cells includes a keratinocyte-SFM basal medium, L-Cysteine, FGF and SDF-1 is disclosed. The culture medium is effective for growing mesenchymal stem cells at a high proliferation rate while maintaining the purity, characterization and undifferentiated state of the cells.

Claims (32)

1. A stem cell growth medium comprising:

(a) serum about 1% to about 10% by volume;

(b) fibroblast growth factor 1 to about 10 ng/ml;

(c) epidermal growth factor 1 to about 10 ng/ml;

(d) hydrocortisone about 10 to about 100 ng/ml;

(e) calcium chloride 0.01 to about 0.1 mM;

(f) insulin about 0.5 to about 5 mg/ml;

(g) bovine pituitary extract about 10 to about 100 μg/ml;

(h) L-cysteine or glutathione about 0.5 to about 5 mM;

(i) selenium about 0.1 to about 1 μg/ml;

(j) stromal-derived factor 1 to about 10 ng/ml;

(k) sodium pyruvate 2 to about 20 mg/ml;

(l) transferrin 0.1 to about 1 mg/ml; and

(m) serum free medium balance to 100% volume.

2. The stem cell growth medium of claim 1 , wherein the serum is human serum.

3. The stem cell growth medium of claim 1 , wherein the serum is fetal bovine serum.

4. The stem cell growth medium of claim 1 , wherein at least one of the FGF or the EGF is recombinant.

5. The stem cell growth medium of claim 1 , wherein the SDF is recombinant SDF.

6. The stem cell growth medium of claim 1 , wherein at least one of the insulin or the transferrin is recombinant.

7. The stem cell growth medium of claim 1 , wherein said medium contains L-cysteine.

8. The stem cell growth medium of claim 1 , wherein said medium contains glutathione.

9. The stem cell growth medium of claim 1 , wherein the serum free medium is Keratinocyte-SFM, Defined Keratinocyte-SFM, MCDB 153, Keratinocyte Growth Medium, DMEM/F12, Ham's F10, Ham's F12 or RPMI 1640.

10. A method of culturing a cell, the method comprising culturing the cell in the stem cell growth medium of claim 1 .

11. The method of claim 10 , wherein said cell is a multipotent stem cell.

12. The method of claim 11 , wherein said multipotent stem cell is derived from adipose tissue.

13. The method of claim 11 , wherein said multipotent stem cell undergoes clonal expansion.

14. The method of claim 11 , wherein said multipotent stem cell is growing attached to a plastic material, showing spindle-shaped morphological features.

15. The method of claim 11 , wherein said multipotent stem cell is induced to undergo adipogenic differentiation.

16. The method of claim 11 , wherein said multipotent stem cell is induced to undergo chondrogenic differentiation.

17. The method of claim 11 , wherein said multipotent stem cell is induced to undergo osteogenic differentiation.

18. The method of claim 11 , wherein said multipotent stem cell expresses immunologically detectable surface expression of responses to CD73, CD90 or CD105, and/or expresses negative immunologically detectable surface expression of CD34, CD45 or HLA-DR.

19. A kit comprising ingredients for preparation of the stem cell growth medium according to claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2016
From: PARK, HYEONGGEUN
To: HOPE BIOSCIENCES LLC
Reel/Frame 038821/0364 →
Continuity (1)
Related Publication 20170313985A1 · Nov 2, 2017